Improving outcomes in early-stage breast cancer.

Stefan Glück, Terry Mamounas

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Early-stage breast cancer is a prevalent malignancy that continues to cause a significant number of cancer-related deaths each year. Current evidence points to suboptimal care in patients with early-stage breast cancer, especially with regard to physician use of guideline-recommended care. Such appropriate treatment regimens as breast-conserving therapy and adjuvant therapy (including radiation therapy, chemotherapy, and hormonal therapy) are underutilized in this patient population. Critical steps toward optimizing the appropriate treatment of early-stage breast cancer and providing the most significant benefits for patients include increasing awareness of potential barriers and developing strategies to overcome them. Improved communication, increased proactive behavior in terms of emerging data, and promotion of clinical trial participation may additionally improve outcomes in this patient population. This review incorporates pertinent oncology literature in a comprehensive overview of early-stage breast cancer treatment, including a review of existing guidelines, race and age disparities, and communication strategies for oncologists. The focus is on appropriate, evidence-based treatment of this patient population.

Original languageEnglish
Pages (from-to)1-15
Number of pages15
JournalOncology (Williston Park, N.Y.)
Volume24
Issue number11 Suppl 4
StatePublished - Oct 1 2010
Externally publishedYes

Fingerprint

Breast Neoplasms
Therapeutics
Communication
Guidelines
Population
Neoplasms
Patient Care
Breast
Radiotherapy
Clinical Trials
Physicians
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Glück, S., & Mamounas, T. (2010). Improving outcomes in early-stage breast cancer. Oncology (Williston Park, N.Y.), 24(11 Suppl 4), 1-15.

Improving outcomes in early-stage breast cancer. / Glück, Stefan; Mamounas, Terry.

In: Oncology (Williston Park, N.Y.), Vol. 24, No. 11 Suppl 4, 01.10.2010, p. 1-15.

Research output: Contribution to journalArticle

Glück, S & Mamounas, T 2010, 'Improving outcomes in early-stage breast cancer.', Oncology (Williston Park, N.Y.), vol. 24, no. 11 Suppl 4, pp. 1-15.
Glück S, Mamounas T. Improving outcomes in early-stage breast cancer. Oncology (Williston Park, N.Y.). 2010 Oct 1;24(11 Suppl 4):1-15.
Glück, Stefan ; Mamounas, Terry. / Improving outcomes in early-stage breast cancer. In: Oncology (Williston Park, N.Y.). 2010 ; Vol. 24, No. 11 Suppl 4. pp. 1-15.
@article{5ad10b05c48743489cae75435c072187,
title = "Improving outcomes in early-stage breast cancer.",
abstract = "Early-stage breast cancer is a prevalent malignancy that continues to cause a significant number of cancer-related deaths each year. Current evidence points to suboptimal care in patients with early-stage breast cancer, especially with regard to physician use of guideline-recommended care. Such appropriate treatment regimens as breast-conserving therapy and adjuvant therapy (including radiation therapy, chemotherapy, and hormonal therapy) are underutilized in this patient population. Critical steps toward optimizing the appropriate treatment of early-stage breast cancer and providing the most significant benefits for patients include increasing awareness of potential barriers and developing strategies to overcome them. Improved communication, increased proactive behavior in terms of emerging data, and promotion of clinical trial participation may additionally improve outcomes in this patient population. This review incorporates pertinent oncology literature in a comprehensive overview of early-stage breast cancer treatment, including a review of existing guidelines, race and age disparities, and communication strategies for oncologists. The focus is on appropriate, evidence-based treatment of this patient population.",
author = "Stefan Gl{\"u}ck and Terry Mamounas",
year = "2010",
month = "10",
day = "1",
language = "English",
volume = "24",
pages = "1--15",
journal = "ONCOLOGY (United States)",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "11 Suppl 4",

}

TY - JOUR

T1 - Improving outcomes in early-stage breast cancer.

AU - Glück, Stefan

AU - Mamounas, Terry

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Early-stage breast cancer is a prevalent malignancy that continues to cause a significant number of cancer-related deaths each year. Current evidence points to suboptimal care in patients with early-stage breast cancer, especially with regard to physician use of guideline-recommended care. Such appropriate treatment regimens as breast-conserving therapy and adjuvant therapy (including radiation therapy, chemotherapy, and hormonal therapy) are underutilized in this patient population. Critical steps toward optimizing the appropriate treatment of early-stage breast cancer and providing the most significant benefits for patients include increasing awareness of potential barriers and developing strategies to overcome them. Improved communication, increased proactive behavior in terms of emerging data, and promotion of clinical trial participation may additionally improve outcomes in this patient population. This review incorporates pertinent oncology literature in a comprehensive overview of early-stage breast cancer treatment, including a review of existing guidelines, race and age disparities, and communication strategies for oncologists. The focus is on appropriate, evidence-based treatment of this patient population.

AB - Early-stage breast cancer is a prevalent malignancy that continues to cause a significant number of cancer-related deaths each year. Current evidence points to suboptimal care in patients with early-stage breast cancer, especially with regard to physician use of guideline-recommended care. Such appropriate treatment regimens as breast-conserving therapy and adjuvant therapy (including radiation therapy, chemotherapy, and hormonal therapy) are underutilized in this patient population. Critical steps toward optimizing the appropriate treatment of early-stage breast cancer and providing the most significant benefits for patients include increasing awareness of potential barriers and developing strategies to overcome them. Improved communication, increased proactive behavior in terms of emerging data, and promotion of clinical trial participation may additionally improve outcomes in this patient population. This review incorporates pertinent oncology literature in a comprehensive overview of early-stage breast cancer treatment, including a review of existing guidelines, race and age disparities, and communication strategies for oncologists. The focus is on appropriate, evidence-based treatment of this patient population.

UR - http://www.scopus.com/inward/record.url?scp=79952212174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952212174&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 1

EP - 15

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

SN - 0890-9091

IS - 11 Suppl 4

ER -